Shandong Weigao Group repurchases shares, boosting treasury holdings

On August 29, 2025, Shandong Weigao Group Medical Polymer Company Limited repurchased 1,260,000 H shares on the Exchange. The shares were acquired at prices ranging from HK$5.83 to HK$6, with an aggregate cost of HK$7,447,900. This transaction increased the company's treasury shares from 9,708,400 to 10,968,400, while the number of issued shares (excluding treasury shares) decreased by 1,260,000 to 4,511,363,924.

The repurchase represents a 0.0279% reduction in the existing number of issued shares (excluding treasury shares) before the event. The company's total issued shares remain at 4,522,332,324. The repurchase was made under a mandate granted on May 27, 2025, which authorized the repurchase of up to 451,560,392 shares.

Following this transaction, the total number of shares repurchased on the Exchange under the current mandate stands at 4,320,000, representing 0.9567% of the issued shares (excluding treasury shares) as at the date of the resolution granting the repurchase mandate. A moratorium period for any new share issues or sales of treasury shares will be in effect until September 29, 2025.